BUENOS AIRES, Dec. 4 (UPI) — Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door…
Newswise — CLEVELAND – Patients with Type 1 Diabetes (T1D) and persistent hypoglycemia can now receive a novel and life-changing treatment at University Hospitals. The breakthrough islet cellular therapy called…
Breakthrough T1DHighlights from the 2025 ISPAD conferenceThe latest type 1 diabetes (T1D) research was presented at the International Society for Pediatric and Adolescent Diabetes annual….1 hour ago
NEW YORK, Nov. 6, 2025 /PRNewswire/ — Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in Houston, demonstrate that finerenone significantly…
PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ — Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA) has…
Throughout November, “See T1D”, creative will appear on billboards and digital displays across 22 major cities including New York, Washington D.C, Boston and San Francisco. A marquee element of the campaign…
Researchers from the University at Albany and New York University Grossman School of Medicine have discovered way to block a key cellular pathway that drives chronic inflammation and impairs wound…
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound…
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its…
Diabetes Stress Management: Development of resilience Living with type 1 diabetes (T1D) is not always easy. You may feel stressed from the recognized stigma of strict management routines, the cost…